Pharmacokinetic Study of Berberine From Rasont and Implication of Lysergol for Its Bioavailability Enhancement

Patil, Shrikant; Dash, Ranjeet Prasad; Anandjiwala, Sheetal; Nivsarkar, Manish

doi:10.1080/10826076.2012.657731

Cited by 4 publications

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Chitosan‐N‐AcetylCystein (Fratter, De Servi, ) and beta‐cyclodextrin have increased the intestinal absorption of berberine because of its solubilizing effect and P‐glycoprotein (P‐gp) modulatory activity (Zhang et al ., ). Lysergol (Patil et al ., ) and sodium caprate (Lv et al ., ; Du et al ., ) are other compounds that have improved the oral bioavailability of berberine.…”

Section: Pharmacokineticmentioning

confidence: 97%

Berberis Vulgaris and Berberine: An Update Review

Imenshahidi

Hosseinzadeh

2016

Phytotherapy Research

265

180

View full text Add to dashboard Cite

Berberine is an isoquinoline alkaloid present in several plants, including Coptis sp. and Berberis sp. Berberine is a customary component in Chinese medicine, and is characterized by a diversity of pharmacological effects. An extensive search in electronic databases (PubMed, Scopus, Ovid, Wiley, ProQuest, ISI, and Science Direct) were used to identify the pharmacological and clinical studies on Berberis vulgaris and berberine, during 2008 to 2015, using 'berberine' and 'Berberis vulgaris' as search words. We found more than 1200 new article studying the properties and clinical uses of berberine and B. vulgaris, for treating tumor, diabetes, cardiovascular disease, hyperlipidemia, inflammation, bacterial and viral infections, cerebral ischemia trauma, mental disease, Alzheimer disease, osteoporosis, and so on. In this article, we have updated the pharmacological effects of B. vulgaris and its active constituent, berberine. Copyright © 2016 John Wiley & Sons, Ltd.

show abstract

Section: Pharmacokineticmentioning

confidence: 97%